Answers are grounded in this paper and cite their sources.
Angioembolization with larger embolic agents is associated with higher long-term efficacy compared to smaller agents. Due to concerns for serious pulmonary complications, we no longer use agents smaller than 150 microns. Prospective studies are necessary to evaluate the optimal embolization technique to achieve durable outcomes without increasing patient morbidity.
No takes yet. Share an insight, caveat, or question.
Villalta et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: